These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1746903)

  • 1. Cancer growth and progression in the framework of comparative oncology. A new approach to cancer therapy.
    Kaiser HE
    Anticancer Res; 1991; 11(4):1453-67. PubMed ID: 1746903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic possibilities and opportunities for comparative oncopathology.
    Kaiser HE
    In Vivo; 1993; 7(6A):553-65. PubMed ID: 8193276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Challenge of Developing New Therapies for Childhood Cancers.
    Balis FM
    Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis of metastatic disease: implications for current therapy and for the development of new therapeutic strategies.
    Poste G
    Cancer Treat Rep; 1986 Jan; 70(1):183-99. PubMed ID: 3510734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in the therapy for large bowel cancer.
    Carter SK
    Cancer; 1982 Dec; 50(11 Suppl):2647-56. PubMed ID: 6182979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Goal of Cancer Treatment.
    Balis FM
    Oncologist; 1998; 3(4):V. PubMed ID: 10388118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Way to New Horizons: Telemedicine in Oncology.
    Schlag PM
    Oncologist; 1997; 2(2):III-IV. PubMed ID: 10388041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment.
    Epstein RJ
    Clin Cancer Res; 2005 Aug; 11(15):5337-41. PubMed ID: 16061845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Problems of tumor progression: doubts or hopes at the turn of the Millennium?].
    Tímár J
    Orv Hetil; 2000 Apr; 141(17):891-9. PubMed ID: 10827469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful therapy must eradicate cancer stem cells.
    Dingli D; Michor F
    Stem Cells; 2006 Dec; 24(12):2603-10. PubMed ID: 16931775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
    Shen RN; Lu L; Kaiser HE; Broxmeyer HE
    In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence cancer stem cells--made by cell fusion?
    Dittmar T; Nagler C; Schwitalla S; Reith G; Niggemann B; Zänker KS
    Med Hypotheses; 2009 Oct; 73(4):542-7. PubMed ID: 19564079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of resistance mechanisms to the growth-inhibitory effects of transforming growth factor-beta during tumor progression.
    Filmus J; Kerbel RS
    Curr Opin Oncol; 1993 Jan; 5(1):123-9. PubMed ID: 8427884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Status of pathophysiologic research in the field of oncology].
    Tereshchenko IP; Kashulina AP
    Patol Fiziol Eksp Ter; 1995; (3):10-5. PubMed ID: 7501426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunogene therapy.
    Yoshizawa H; Kagamu H; Gejyo F
    Arch Immunol Ther Exp (Warsz); 2001; 49(5):337-43. PubMed ID: 11798131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR guided cancer treatment system for an elevated therapeutic index - a macroscopic approach.
    Myhr G
    Med Hypotheses; 2008; 70(3):665-70. PubMed ID: 17765401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new era of cancer therapy: cancer cell targeted therapies are coming of age.
    Voltz E; Gronemeyer H
    Int J Biochem Cell Biol; 2008; 40(1):1-8. PubMed ID: 17951100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.